Hansa Biopharma Reports Second Quarter and Interim ..
-
Hansa Biopharma Reports Second Quarter and Interim January-June 2025 Financial Results
Hansa Biopharma Reports Second Quarter and Interim January-June 2025 Financial Results
· Hansa secures directed cash share issue of approximately 232 MSEK/US $24.3M and restructures
News Powered by Cision (news.cision.com)
-
Half Year Report January - July 2025
https://www.hansabiopharma.com/files/Main/1219/4208006/20250717_hnsa_q22025_quarterlyreport_eng.pdf
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind